Elekta stock heads into the open after a 0.6% slip

At the close on September 17, 2026, Elekta stock traded at SEK 51.40 on Nasdaq Stockholm, down 0.58% for the day, as insider share purchases drew attention alongside moderate volume and a move in line with the broader Swedish market.

Elekta stock closed at SEK 51.40 on Nasdaq Stockholm on September 17, 2026, down 0.58% from the previous session according to quote data cited in Swedish market coverage. The move kept the share price close to recent levels, with trading roughly in line with broader Swedish equities on the day.

September 17, 2026 in numbers

Elekta AB (ISIN SE0000163628, Nasdaq Stockholm: EKTA B) finished the September 17, 2026 session at SEK 51.40 on Nasdaq Stockholm, marking a 0.58% decline from the prior close as reported in a Swedish market brief that listed Elekta B with a latest price of SEK 51.40 and a one day percent change of negative 0.58%. Per the same market data overview, the session level stayed close to an earlier reference price of SEK 51.55 seen during the week, indicating only a narrow fluctuation band around the low 50s in SEK for the Elekta B share over recent days.

As Placera reported on September 17, 2026, Elekta's chief financial officer Klara Eiritz bought 3,655 Elekta B shares on that date at a price of SEK 51.40 per share, a transaction of almost SEK 0.2 million that highlighted executive confidence at the prevailing valuation. The same note showed Elekta B at SEK 51.40 with a one day performance of minus 0.58%, underlining that the insider purchase occurred as the stock eased slightly within its recent trading range. Against this backdrop, Elekta's move appeared broadly consistent with moderate shifts seen in Nordic healthcare and the wider Swedish equity market during the session.

Today’s drivers for Elekta

Today, September 18, 2026, investors are set to digest the latest insider activity, with the disclosed purchase by Elekta's chief financial officer likely to remain a talking point as the market reopens. The transaction, highlighted by Placera, may frame sentiment around governance and management's view of Elekta's prospects as trading in the Elekta B share resumes. Broader market conditions in Europe, including sector moves in medical technology and health care, will also shape Elekta's path into today's session as investors balance company specific signals with regional index performance.